Medifast (MEX:MED) Cyclically Adjusted Revenue per Share: MXN1,430.64 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:MED Medifast Inc MEX:MED
66 GF Score
Price MXN180.00
GF Value MXN145.90
! 2 Warning Signs
View Full Analysis

What is Medifast Cyclically Adjusted Revenue per Share?

Medifast MEX:MED 66 Cyclically Adjusted Revenue per Share is MXN1,430.64 as of Mar. 2026. GuruFocus rates MEX:MED with a GF Score™ of 66/100 and a GF Value™ of MXN145.90. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Medifast's adjusted revenue per share for the three months ended in Mar. 2026 was MXN124.594. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is MXN1,430.64 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Medifast's average Cyclically Adjusted Revenue Growth Rate was 3.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 16.90% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 19.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Medifast was 35.10% per year. The lowest was 7.80% per year. And the median was 19.80% per year.

As of today (2026-07-15), Medifast's current stock price is MXN180.00. Medifast's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was MXN1,430.64. Medifast's Cyclically Adjusted PS Ratio of today is 0.13.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medifast was 10.96. The lowest was 0.12. And the median was 2.36.


Medifast  (MEX:MED) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Medifast's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=180.00/1430.64
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Medifast was 10.96. The lowest was 0.12. And the median was 2.36.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Medifast Cyclically Adjusted Revenue per Share Related Terms


Medifast Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Medifast's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medifast Cyclically Adjusted Revenue per Share Chart

Medifast Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 999.54 1,230.45 1,407.71 1,639.95 2,793.31

Medifast Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,178.64 2,112.38 2,188.09 2,793.31 1,430.64

MEX:MED vs RGS, EVTK, DROR: Cyclically Adjusted Revenue per Share Comparison

For the Personal Services subindustry, Medifast's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medifast Cyclically Adjusted PS Ratio vs Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Medifast's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medifast's Cyclically Adjusted PS Ratio falls into.


MEX:MED
66GF Score
Medifast Inc MEX:MED
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medifast Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medifast's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=124.594/330.2130*330.2130
=124.594

Current CPI (Mar. 2026) = 330.2130.

Medifast Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 110.712 241.018 151.684
201609 110.980 241.428 151.793
201612 107.207 241.432 146.630
201703 110.729 243.801 149.975
201706 113.543 244.955 153.062
201709 115.843 246.819 154.983
201712 125.957 246.524 168.716
201803 147.562 249.554 195.256
201806 189.367 251.989 248.151
201809 215.298 252.439 281.629
201812 239.036 251.233 314.182
201903 262.881 254.202 341.487
201906 294.160 256.143 379.224
201909 310.997 256.759 399.967
201912 269.389 256.974 346.166
202003 353.903 258.115 452.757
202006 429.578 257.797 550.248
202009 505.781 260.280 641.676
202012 443.572 260.474 562.333
202103 586.114 264.877 730.688
202106 661.724 271.696 804.244
202109 721.275 274.310 868.267
202112 660.662 278.802 782.488
202203 714.456 287.504 820.589
202206 797.565 296.311 888.817
202209 711.181 296.808 791.223
202212 597.884 296.797 665.199
202303 577.156 301.836 631.417
202306 465.129 305.109 503.399
202309 375.796 307.789 403.175
202312 297.217 306.746 319.955
202403 264.648 312.332 279.799
202406 282.344 314.175 296.757
202409 251.559 315.301 263.456
202412 226.140 315.605 236.607
202503 216.257 319.799 223.299
202506 179.703 322.561 183.966
202509 149.225 324.800 151.712
202512 123.002 324.054 125.340
202603 124.594 330.213 124.594

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of MXN1,430.64 mean?
Medifast (MEX:MED) has a Cyclically Adjusted Revenue per Share of MXN1,430.64 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medifast and its competitors.
Is Medifast's Cyclically Adjusted Revenue per Share too high?
Medifast's current Cyclically Adjusted Revenue per Share is MXN1,430.64. Overall, Medifast has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does Medifast's Cyclically Adjusted Revenue per Share compare to RGS and EVTK?
Medifast's Cyclically Adjusted Revenue per Share of MXN1,430.64 can be compared against companies in the Personal Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Personal Services company?
A good Cyclically Adjusted Revenue per Share depends on the Personal Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Medifast and its competitors. Medifast's current Cyclically Adjusted Revenue per Share is MXN1,430.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Medifast (MEX:MED) has a current Cyclically Adjusted Revenue per Share of MXN1,430.64. The stock's GF Value™ is MXN145.90, compared to a current price of MXN180.00 — trading 23.4% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is MXN1,430.64. Medifast's overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Medifast (MEX:MED), the current Cyclically Adjusted Revenue per Share is MXN1,430.64 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medifast (MEX:MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medifast stock appears to be overvalued. The current stock price of MXN180.00 is trading 23.4% above its estimated GF Value™ of MXN145.90.

Key valuation signals for MEX:MED:

  • Cyclically Adjusted Revenue per Share: MXN1,430.64
  • GF Value™: MXN145.90 vs. price of MXN180.00 (23.4% above fair value)
  • GF Score™: 66/100 with 2 warning signs

No single metric tells the full story. See the MEX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medifast Business Description

Other Exchanges MED:USA0K05:UKMDF:Germany
Address 100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
66GF Score

Get the complete analysis for MEX:MED

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN180.00
Price
MXN145.90
GF Value